The present invention is related to a process for the preparation of a substituted phenothiazine of the general formula V
wherein R1 and R2 are each independently selected from the group consisting of but not limited to H, alkyl, aryl, hydroxyl, methoxy, acetoxy, halide,
by the condensation reaction of substitu...
ABSTRACT
A process is provided for the preparation of N-debocdocetaxel (I), a common. .
intermediate for the preparation paclitaxel and docetaxel. The process comprises
the following steps: . a) coupling of 7,10-di-O-chloroacetyl-10-deacetylbaccatin III (III) with (4R,5S)-5-thoxyoxycarbonyl-2-(4-methoxyphenyl...
The present invention relates to an improved process for the preparation of diphenoxylate hydrochloride of the formula (I) by condensing 4-Bromo-2,2-diphenylbutanenitrile ( II) and Ethyl 4-phenylpiperidine-4-carboxylate (III) in aqueous medium under basic conditions in the presence of a catalyst. This invention also...
The present invention relates to the synthesis of 2-chloromalonaldhyde, a key intermediate in the synthesis of etoricoxib, which is a pharmaceutically active ingredient inhibiting cyclooxygenase-2 and used as a non-steroidal anti-inflammatory drug. In particular, the application concerns a single-step process of syn...
A process for the preparation of Bis-(l(2)H-tetrazol-5-yl)-amine monohydrate.
This preparation process is carried out by the reaction between sodium dicynamide and sodium azide in presence of a dilute solution of an inorganic acid solution in aqueous medium.
The present invention is related to a process for the preparation of flurbiprofen of the general formula I in high purity
from 2,4-difluoro nitrobenzene (II)
and diethylmethyl malonate (III).
The present invention relates to the synthesis of phenylephrine hydrochloride from 3-hydroxyacetophenone, and is generally used as a decongestant. In particular, the process is a high yield process, easy to perform, industrially viable apart from the usage of commercially available raw materials. Also, the chiral pu...
The present invention relates to the synthesis of levo free (+)-3-methoxymorphinan hydrochloride, an intermediate for anti-tussive agent. In particular, the process involves the use of commercially available agents HCl, methanol, and acetone, to obtain the levo free (+)-3-methoxymorphinan hydrochloride from a racemi...
[Class : 5] Medicinal & Pharmaceutical And Chemical Preparations For Medical And Pharmaceutical Purposes And Substances, All Being Goods Included In Class 5.
Renewal of trademark is overdue. Renewal request with surcharge in prescribed form is to be filed by the applicant.
[Class : 5] Medicinal & Pharmaceutical And Chemical Preparations For Medical And Pharmaceutical Purposes And Substances All Being Goods Inclused In Class 5 For Sale In The State Of Andhra Pradesh Only.
Renewal of trademark is overdue. Renewal request with surcharge in prescribed form is to be filed by the applicant.
View +13 more Brands for Hy Gro Chemicals Pharmtek Private Limited.
Charges
30 Crore
24 May 1996
Indian Overseas Bank
30 Crore
14 October 2010
Indian Overseas Bank
2 Crore
24 May 1996
Indian Overseas Bank
0
14 October 2010
Indian Overseas Bank
0
24 May 1996
Indian Overseas Bank
0
14 October 2010
Indian Overseas Bank
0
Documents
Form MSME FORM I-30042024_signed
Form AOC-4(XBRL)-04122023_signed
Form MGT-7-09112023_signed
Copy of MGT-8-03112023
List of share holders, debenture holders;-03112023
Form MSME FORM I-19102023_signed
XBRL financial statements duly authenticated as per section 134 (including Board's report,auditor's report and other documents)-17102023
Form AOC-4(XBRL)-17102023
Form MGT-7-28092023_signed
Form AOC-4(XBRL)-21092023_signed
Form MSME FORM I-11092023_signed
Form MSME FORM I-29082023_signed
Form MSME FORM I-28042023_signed
Form AOC-5-05012023-signed
Form AOC-5-27122022
Copy of board resolution-27122022
List of share holders, debenture holders;-24112022
Copy of MGT-8-24112022
Form MGT-7-24112022
Form MSME FORM I-01112022
XBRL financial statements duly authenticated as per section 134 (including Board's report,auditor's report and other documents)-29102022
Form AOC-4(XBRL)-29102022
Optional Attachment-(4)-07072022
Form CHG-1-07072022_signed
Optional Attachment-(3)-07072022
Optional Attachment-(1)-07072022
Instrument(s) of creation or modification of charge;-07072022
Optional Attachment-(5)-07072022
Optional Attachment-(2)-07072022
CERTIFICATE OF REGISTRATION FOR MODIFICATION OF CHARGE-20220707